These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 20706274)

  • 1. Rocaglamide breaks TRAIL resistance in HTLV-1-associated adult T-cell leukemia/lymphoma by translational suppression of c-FLIP expression.
    Bleumink M; Köhler R; Giaisi M; Proksch P; Krammer PH; Li-Weber M
    Cell Death Differ; 2011 Feb; 18(2):362-70. PubMed ID: 20706274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wogonin and related natural flavones overcome tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) protein resistance of tumors by down-regulation of c-FLIP protein and up-regulation of TRAIL receptor 2 expression.
    Ding J; Polier G; Köhler R; Giaisi M; Krammer PH; Li-Weber M
    J Biol Chem; 2012 Jan; 287(1):641-649. PubMed ID: 22086925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The eIF4E/eIF4G interaction inhibitor 4EGI-1 augments TRAIL-mediated apoptosis through c-FLIP Down-regulation and DR5 induction independent of inhibition of cap-dependent protein translation.
    Fan S; Li Y; Yue P; Khuri FR; Sun SY
    Neoplasia; 2010 Apr; 12(4):346-56. PubMed ID: 20360945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human T-cell leukemia virus type 1 Tax-deregulated autophagy pathway and c-FLIP expression contribute to resistance against death receptor-mediated apoptosis.
    Wang W; Zhou J; Shi J; Zhang Y; Liu S; Liu Y; Zheng D
    J Virol; 2014 Mar; 88(5):2786-98. PubMed ID: 24352466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rocaglamide overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells by attenuating the inhibition of caspase-8 through cellular FLICE-like-inhibitory protein downregulation.
    Luan Z; He Y; He F; Chen Z
    Mol Med Rep; 2015 Jan; 11(1):203-11. PubMed ID: 25333816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rocaglamide sensitizes leukemic T cells to activation-induced cell death by differential regulation of CD95L and c-FLIP expression.
    Zhu JY; Giaisi M; Köhler R; Müller WW; Mühleisen A; Proksch P; Krammer PH; Li-Weber M
    Cell Death Differ; 2009 Sep; 16(9):1289-99. PubMed ID: 19373244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin sensitizes human bladder cancer cells to TRAIL-induced apoptosis through mTOR/S6K1-mediated downregulation of c-FLIP.
    Zhang T; Wang X; He D; Jin X; Guo P
    Anticancer Drugs; 2014 Sep; 25(8):887-97. PubMed ID: 24714080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rocaglamide and a XIAP inhibitor cooperatively sensitize TRAIL-mediated apoptosis in Hodgkin's lymphomas.
    Giaisi M; Köhler R; Fulda S; Krammer PH; Li-Weber M
    Int J Cancer; 2012 Aug; 131(4):1003-8. PubMed ID: 21952919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human T-cell leukemia virus type-I oncoprotein Tax inhibits Fas-mediated apoptosis by inducing cellular FLIP through activation of NF-kappaB.
    Okamoto K; Fujisawa J; Reth M; Yonehara S
    Genes Cells; 2006 Feb; 11(2):177-91. PubMed ID: 16436054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CK2 controls TRAIL and Fas sensitivity by regulating FLIP levels in endometrial carcinoma cells.
    Llobet D; Eritja N; Encinas M; Llecha N; Yeramian A; Pallares J; Sorolla A; Gonzalez-Tallada FJ; Matias-Guiu X; Dolcet X
    Oncogene; 2008 Apr; 27(18):2513-24. PubMed ID: 17982483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphatidylinositol 3-kinase/Akt activity regulates c-FLIP expression in tumor cells.
    Panka DJ; Mano T; Suhara T; Walsh K; Mier JW
    J Biol Chem; 2001 Mar; 276(10):6893-6. PubMed ID: 11145953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual modulation of Ras-Mnk and PI3K-AKT-mTOR pathways: A Novel c-FLIP inhibitory mechanism of 3-AWA mediated translational attenuation through dephosphorylation of eIF4E.
    ur Rasool R; Rah B; Amin H; Nayak D; Chakraborty S; Rawoof A; Mintoo MJ; Yousuf K; Mukherjee D; Kumar LD; Mondhe DM; Goswami A
    Sci Rep; 2016 Jan; 6():18800. PubMed ID: 26728896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotic agent thioridazine sensitizes renal carcinoma Caki cells to TRAIL-induced apoptosis through reactive oxygen species-mediated inhibition of Akt signaling and downregulation of Mcl-1 and c-FLIP(L).
    Min KJ; Seo BR; Bae YC; Yoo YH; Kwon TK
    Cell Death Dis; 2014 Feb; 5(2):e1063. PubMed ID: 24556678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor receptor-mediated tissue transglutaminase overexpression couples acquired tumor necrosis factor-related apoptosis-inducing ligand resistance and migration through c-FLIP and MMP-9 proteins in lung cancer cells.
    Li Z; Xu X; Bai L; Chen W; Lin Y
    J Biol Chem; 2011 Jun; 286(24):21164-72. PubMed ID: 21525012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HTLV-1 Tax protects against CD95-mediated apoptosis by induction of the cellular FLICE-inhibitory protein (c-FLIP).
    Krueger A; Fas SC; Giaisi M; Bleumink M; Merling A; Stumpf C; Baumann S; Holtkotte D; Bosch V; Krammer PH; Li-Weber M
    Blood; 2006 May; 107(10):3933-9. PubMed ID: 16403915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of RIP and c-FLIP enhances TRAIL-induced apoptosis in pancreatic cancer cells.
    Wang P; Zhang J; Bellail A; Jiang W; Hugh J; Kneteman NM; Hao C
    Cell Signal; 2007 Nov; 19(11):2237-46. PubMed ID: 17693058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human astrocytes are resistant to Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.
    Song JH; Bellail A; Tse MC; Yong VW; Hao C
    J Neurosci; 2006 Mar; 26(12):3299-308. PubMed ID: 16554480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by dimethyl-celecoxib in human non small-cell lung cancer cells.
    Chen S; Liu X; Yue P; Schönthal AH; Khuri FR; Sun SY
    Mol Pharmacol; 2007 Nov; 72(5):1269-79. PubMed ID: 17684158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of apoptosis in 9-nitrocamptothecin-treated DU145 human prostate carcinoma cells correlates with de novo synthesis of CD95 and CD95 ligand and down-regulation of c-FLIP(short).
    Chatterjee D; Schmitz I; Krueger A; Yeung K; Kirchhoff S; Krammer PH; Peter ME; Wyche JH; Pantazis P
    Cancer Res; 2001 Oct; 61(19):7148-54. PubMed ID: 11585748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of c-FLIP(L) and c-FLIP(S) as critical regulators of death receptor-induced apoptosis in pancreatic cancer cells.
    Haag C; Stadel D; Zhou S; Bachem MG; Möller P; Debatin KM; Fulda S
    Gut; 2011 Feb; 60(2):225-37. PubMed ID: 20876774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.